G730-0797 Screening compound: N~3~-isopropyl-7,8,9,10-tetrahydro-6H-azepino[1,2-a][1,3]benzimidazole-3-carboxamide

G730-0797 Screening compound: N~3~-isopropyl-7,8,9,10-tetrahydro-6H-azepino[1,2-a][1,3]benzimidazole-3-carboxamide
G730-0797 Screening compound: N~3~-isopropyl-7,8,9,10-tetrahydro-6H-azepino[1,2-a][1,3]benzimidazole-3-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G730-0797
N~3~-isopropyl-7,8,9,10-tetrahydro-6H-azepino[1,2-a][1,3]benzimidazole-3-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G730-0797

Molecular Formula

C16H21N3O (C16 H21 N3 O)

Compound Name

N~3~-isopropyl-7,8,9,10-tetrahydro-6H-azepino[1,2-a][1,3]benzimidazole-3-carboxamide

IUPAC name

N-(propan-2-yl)-18-diazatricyclo[7.5.0.0^{27}]tetradeca-2(7)358-tetraene-5-carboxamide

SMILES

CC(C)NC(c(cc1)cc2c1n(CCCCC1)c1n2)=O

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

271.36

Hydrogen Bond Acceptors Count

3.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

3.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

2.605

Distribution Coefficient, logD

2.603

Water Solubility, LogSw

-3.08

Polar Surface Area

35.430

Acid Dissociation Constant (pKa)

14.08

Base Dissociation Constant (pKb)

5.12

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

50.00

G730-0797 in Drug Discovery

Included in Screening Libraries

3D-Diversity Natural-Product-Like Library (18102 compounds)

Cardiovascular Library (22201 compounds)

DGK Inhibitors Library (10558 compounds)

Fragments Library (11262 compounds)

Protein-Protein Interaction Library (218420 compounds)

STING Agonist Library (5895 compounds)

Targeted Diversity Library (40567 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Epigenetics Focused Set (26518 compounds)

Recognition Elements PPI Library (24135 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
  • Fragments
  • Cyclic compounds
  • Mimetics
Therapeutical areas:
  • Cardiovascular
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
  • Cancer
  • Immune system
Targets:
  • Kinases
  • Others
Mechanism of action:
  • PPI modulators
  • PPI modulators

References: we are preparing a list of scientific research reports with G730-0797 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G730-0797?
Check Price and Availability of G730-0797, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G730-0797 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G730-0797
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G730-0797
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G730-0797 available by request